Literature DB >> 2084144

Anti-double-stranded DNA antibodies in the healthy elderly: prevalence and characteristics.

A Ruffatti1, A Calligaro, T Del Ross, M T Bertoli, A Doria, L Rossi, S Todesco.   

Abstract

Using Crithidia luciliae fluorescent assay a significant prevalence (7.6%; P less than 0.006) of anti-double-stranded DNA antibodies was found in a healthy old population. A negative enzyme-linked immunosorbent assay for anti-total histone antibodies excluded a false-positive reaction. Anti-double-stranded DNA antibodies in the aged differed from those found in patients with systemic lupus erythematosus and were characterized by a low titer (95.6% of cases), belonging to the IgA class alone (95.6%), no complement-fixing ability (100%), and negativity to Farr assay (100%). It is concluded that, in elderly subjects without signs and symptoms of disease, including systemic lupus erythematosus, such a peculiar anti-double-stranded DNA antibody may be detected.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2084144     DOI: 10.1007/BF00917474

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  25 in total

1.  The first international standard for antibodies to double stranded DNA.

Authors:  T E Feltkamp; T B Kirkwood; R N Maini; L A Aarden
Journal:  Ann Rheum Dis       Date:  1988-09       Impact factor: 19.103

2.  Failure to detect age-related increase of non-pathological autoantibodies.

Authors:  J Gordon; M Rosenthal
Journal:  Lancet       Date:  1984-01-28       Impact factor: 79.321

3.  Admission criteria for immunogerontological studies in man: the SENIEUR protocol.

Authors:  G J Ligthart; J X Corberand; C Fournier; P Galanaud; W Hijmans; B Kennes; H K Müller-Hermelink; G G Steinmann
Journal:  Mech Ageing Dev       Date:  1984-11       Impact factor: 5.432

4.  The role of the laboratory in rheumatology. Antibodies to nuclear and other intracellular antigens in the connective tissue diseases.

Authors:  D Alarcón-Segovia
Journal:  Clin Rheum Dis       Date:  1983-04

Review 5.  Antinuclear antibodies in autoimmune disease. Significance and pathogenicity.

Authors:  C E Harmon
Journal:  Med Clin North Am       Date:  1985-05       Impact factor: 5.456

Review 6.  Autoantibodies and their relation to rheumatic diseases.

Authors:  G A McCarty
Journal:  Med Clin North Am       Date:  1986-03       Impact factor: 5.456

7.  Immunochemical characteristics of antibodies to DNA in patients with active systemic lupus erythematosus.

Authors:  S P Ballou; I Kushner
Journal:  Clin Exp Immunol       Date:  1979-07       Impact factor: 4.330

8.  High prevalence of anti-cardiolipin and other autoantibodies in a healthy elderly population.

Authors:  M N Manoussakis; A G Tzioufas; M P Silis; P J Pange; J Goudevenos; H M Moutsopoulos
Journal:  Clin Exp Immunol       Date:  1987-09       Impact factor: 4.330

9.  Anti-DNA antibodies: the choice of assays for routine diagnostic work.

Authors:  H Sarvas; M Gripenberg; M Leirisalo-Repo
Journal:  Acta Pathol Microbiol Immunol Scand C       Date:  1985-02

10.  Avidity of antibodies to dsDNA: comparison of IFT on Crithidia luciliae, Farr assay, and PEG assay.

Authors:  R Smeenk; G van der Lelij; L Aarden
Journal:  J Immunol       Date:  1982-01       Impact factor: 5.422

View more
  16 in total

1.  Correction for age of anticardiolipin antibodies cut-off points.

Authors:  E Rapizzi; A Ruffatti; M Tonello; A Piccoli; A Calligaro; P Sfriso; S Todesco
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

2.  Stability of natural self-reactive antibody repertoires during aging.

Authors:  S Lacroix-Desmazes; L Mouthon; S V Kaveri; M D Kazatchkine; M E Weksler
Journal:  J Clin Immunol       Date:  1999-01       Impact factor: 8.317

Review 3.  The use of laboratory tests in the diagnosis of SLE.

Authors:  W Egner
Journal:  J Clin Pathol       Date:  2000-06       Impact factor: 3.411

Review 4.  Elderly-onset systemic lupus erythematosus: prevalence, clinical course and treatment.

Authors:  Deana Lazaro
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

Review 5.  Systemic lupus erythematosus biomarkers: the challenging quest.

Authors:  Cristina Arriens; Jonathan D Wren; Melissa E Munroe; Chandra Mohan
Journal:  Rheumatology (Oxford)       Date:  2017-04-01       Impact factor: 7.580

6.  Anticyclic Citrullinated Peptide Antibodies 3.1 and Anti-CCP-IgA Are Associated with Increasing Age in Individuals Without Rheumatoid Arthritis.

Authors:  Heather M Berens; Kristen J Polinski; Ted R Mikuls; Sonia Khatter; Justin August; Ashley Visser; Michael Mahler; Michael H Weisman; James R O'Dell; Richard M Keating; Jane H Buckner; Peter K Gregersen; Jill M Norris; V Michael Holers; Kevin D Deane; M Kristen Demoruelle
Journal:  J Rheumatol       Date:  2019-04-15       Impact factor: 4.666

Review 7.  Cytoplasmic DNA: sources, sensing, and role in aging and disease.

Authors:  Karl N Miller; Stella G Victorelli; Hanna Salmonowicz; Nirmalya Dasgupta; Tianhui Liu; João F Passos; Peter D Adams
Journal:  Cell       Date:  2021-10-28       Impact factor: 41.582

8.  Late onset systemic lupus erythematosus: no substantial differences using different cut-off ages.

Authors:  Melissa Padovan; Marcello Govoni; Gabriella Castellino; Nicoletta Rizzo; Maria Fotinidi; Francesco Trotta
Journal:  Rheumatol Int       Date:  2006-12-29       Impact factor: 3.580

9.  The janus head of T cell aging - autoimmunity and immunodeficiency.

Authors:  Jörg J Goronzy; Guangjin Li; Zhen Yang; Cornelia M Weyand
Journal:  Front Immunol       Date:  2013-06-04       Impact factor: 7.561

10.  Acute renal failure secondary to tuberculosis: a diagnostic challenge.

Authors:  Saeed I Khilji; Hong Kuan Kok; Limy Wong; Anthony M Dorman; J Joseph Walshe
Journal:  Case Rep Nephrol       Date:  2012-02-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.